COMP <GO>
DOC vs BRK-B // ALTMAN Z-SCORE & DEBT/EQUITY
Healthpeak Properties Inc. (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: DOC 5
— BRK-B 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: BRK-B
LAST: $19.03 (+0.48%) • MKT CAP: $13.06B
balance-sheet
1.12
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
balance-sheet
2.85
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOC VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOC | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.60% | 11.47% | -10.87 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 9.7x | +85.32 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 9.38% | 2.09% | +7.29 | DOC | /fcf-yield <GO> |
| Operating Margin | 14.40% | 27.80% | -13.40 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 11.80% | 22.30% | -10.50 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 3.93% | +2.27 | DOC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.50% | 0.00% | +6.50 | DOC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.12 | 2.85 | -1.73 | BRK-B | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | DOC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 3.55% | +3.45 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.9 | 66.8 | -19.93 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.61 | +0.41 | DOC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 24.3x | +115.66 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.06B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOC REV | BRK-B REV | DOC GROSS % | BRK-B GROSS % | DOC FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $604.0M | $371.44B | 44.0% | — | $1.22B | $25.04B |
| FY 2024 | $568.5M | $371.43B | -89.1% | — | $1.04B | $11.62B |
| FY 2023 | $527.4M | $364.48B | 44.0% | — | $932.5M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOC // BETA 1.02
BRK-B // BETA 0.61